125 related articles for article (PubMed ID: 15138621)
21. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.
Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Visakorpi T; Isola J
Genes Chromosomes Cancer; 1997 Feb; 18(2):94-101. PubMed ID: 9115969
[TBL] [Abstract][Full Text] [Related]
22. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma.
Uchida T; Wada C; Wang C; Egawa S; Ohtani H; Koshiba K
Cancer Res; 1994 Jul; 54(14):3682-5. PubMed ID: 8033084
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
24. [Microsatellite instability in renal cell carcinoma and bladder tumors].
Matsuda H; Uejima S; Kurita T
Hinyokika Kiyo; 1996 Jan; 42(1):27-31. PubMed ID: 8686579
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
[TBL] [Abstract][Full Text] [Related]
26. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
27. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
[TBL] [Abstract][Full Text] [Related]
28. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.
Alimov A; Kost-Alimova M; Liu J; Li C; Bergerheim U; Imreh S; Klein G; Zabarovsky ER
Oncogene; 2000 Mar; 19(11):1392-9. PubMed ID: 10723130
[TBL] [Abstract][Full Text] [Related]
29. Genetic progression of renal cell carcinoma.
Moch H; Mihatsch MJ
Virchows Arch; 2002 Oct; 441(4):320-7. PubMed ID: 12404056
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
[TBL] [Abstract][Full Text] [Related]
31. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
Prat E; Bernués M; Del Rey J; Camps J; Ponsa I; Algaba F; Egozcue J; Caballín MR; Gelabert A; Miró R
Cancer Genet Cytogenet; 2006 Jan; 164(2):142-7. PubMed ID: 16434318
[TBL] [Abstract][Full Text] [Related]
32. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
Gonzalgo ML; Yegnasubramanian S; Yan G; Rogers CG; Nicol TL; Nelson WG; Pavlovich CP
Clin Cancer Res; 2004 Nov; 10(21):7276-83. PubMed ID: 15534102
[TBL] [Abstract][Full Text] [Related]
34. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
[TBL] [Abstract][Full Text] [Related]
35. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.
Moch H; Presti JC; Sauter G; Buchholz N; Jordan P; Mihatsch MJ; Waldman FM
Cancer Res; 1996 Jan; 56(1):27-30. PubMed ID: 8548768
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide differences between microsatellite stable and unstable colorectal tumors.
Camps J; Armengol G; del Rey J; Lozano JJ; Vauhkonen H; Prat E; Egozcue J; Sumoy L; Knuutila S; Miró R
Carcinogenesis; 2006 Mar; 27(3):419-28. PubMed ID: 16272173
[TBL] [Abstract][Full Text] [Related]
37. Detection of mononucleotide repeat sequence alterations in a large background of normal DNA for screening high-frequency microsatellite instability cancers.
Sun X; Liu Y; Lutterbaugh J; Chen WD; Markowitz SD; Guo B
Clin Cancer Res; 2006 Jan; 12(2):454-9. PubMed ID: 16428486
[TBL] [Abstract][Full Text] [Related]
38. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
39. Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer.
Harada T; Okita K; Shiraishi K; Kusano N; Kondoh S; Sasaki K
Cancer Res; 2002 Feb; 62(3):835-9. PubMed ID: 11830540
[TBL] [Abstract][Full Text] [Related]
40. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
